← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Horace Mann Educators Corporation (HMN) 10-Year Financial Performance & Capital Metrics

HMN • • Insurance & Managed Care
Financial ServicesProperty & Casualty InsurancePersonal Lines InsuranceRegional Personal Lines
AboutHorace Mann Educators Corporation, together with its subsidiaries, operates as an insurance holding company in the United States. It operates in three segments: Property & Casualty, Life & Retirement, and Supplemental & Group Benefits. The company underwrites and markets personal lines of property and casualty insurance, including personal lines auto and property insurance products; supplemental insurance products, which include cancer, heart, hospital, supplemental disability, and accident coverages; retirement products, such as tax-qualified fixed and variable annuities; and life insurance products comprising whole life and term, as well as indexed universal life insurance products. It also offers student loan solutions, including online student loan management accounts for educators. The company markets its products through its sales force of full-time exclusive agents to K-12 teachers, administrators, and other employees of public schools and their families. Horace Mann Educators Corporation was founded in 1945 and is headquartered in Springfield, Illinois.Show more
  • Revenue $1.55B +8.2%
  • Combined Ratio 91.71% -4.8%
  • Net Income $103M +128.4%
  • Return on Equity 8.35% +110.9%
  • Medical Cost Ratio 69.14% -7.9%
  • Operating Margin 8.29% +123.0%
  • Net Margin 6.63% +111.1%
  • ROA 0.72% +119.0%
  • Equity / Assets 8.89% +6.2%
  • Book Value per Share 31.02 +9.3%
  • Tangible BV/Share 25.96 +13.1%
  • Debt/Equity 0.42 -8.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 91.7% combined ratio
  • ✓Strong Piotroski F-Score: 7/9
  • ✓15 consecutive years of dividend growth
  • ✓Healthy dividend yield of 3.1%
  • ✓Trading at only 1.4x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 4.6%
  • ✗Profits declining 11.0% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y3.87%
5Y1.99%
3Y7.43%
TTM3.97%

Profit (Net Income) CAGR

10Y-0.14%
5Y-11.03%
3Y-15.5%
TTM57.64%

EPS CAGR

10Y0.04%
5Y-10.83%
3Y-9.89%
TTM57.37%

ROCE

10Y Avg0.96%
5Y Avg0.84%
3Y Avg0.47%
Latest0.9%

Peer Comparison

Regional Personal Lines
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
NODKNI Holdings, Inc.274.26M13.3155.466.97%0.87%1.06%13.68%
HMNHorace Mann Educators Corporation1.74B42.8817.298.21%10.24%11.39%25.91%0.42
SAFTSafety Insurance Group, Inc.1.14B76.4916.0019.85%7.13%9.7%10.91%0.06
UFCSUnited Fire Group, Inc.912.14M35.7514.9613.98%8.22%12.38%36.01%0.15
DGICADonegal Group Inc.608.25M19.5812.806.71%8.72%13.73%11.09%0.06
MCYMercury General Corporation5.06B91.3910.8218.27%7.55%19.69%19.58%0.30
KINSKingstone Companies, Inc.225.09M15.9110.757.6%14.2%0.02%24.71%0.17
KMPRKemper Corporation2.26B38.617.86-5.74%5.14%9.14%14.59%0.50

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+1.08B1.13B1.17B1.18B1.4B1.29B1.25B1.34B1.43B1.55B
Revenue Growth %0.02%0.04%0.04%0%0.19%-0.08%-0.03%0.07%0.07%0.08%
Medical Costs & Claims+778.13M829.76M883.13M953.65M907.1M873.4M841.3M1.01B1.08B1.07B
Medical Cost Ratio %----------
Gross Profit+302.32M299.15M288.42M222.54M497.7M416.1M409M332.5M356.8M478.4M
Gross Margin %----------
Gross Profit Growth %-0.06%-0.01%-0.04%-0.23%1.24%-0.16%-0.02%-0.19%0.07%0.34%
Operating Expenses+172.87M184.92M199.74M203.01M261.3M256.5M198.9M316M303.5M349.8M
OpEx / Revenue %----------
Depreciation & Amortization006.62M7.36M15.6M23.4M18.4M27.6M26.2M26.4M
Combined Ratio %----------
Operating Income+129.45M114.23M88.69M19.54M236.4M159.6M210.1M16.5M53.3M128.6M
Operating Margin %----------
Operating Income Growth %-0.11%-0.12%-0.22%-0.78%11.1%-0.32%0.32%-0.92%2.23%1.41%
EBITDA+142.57M126.04M95.3M26.89M252M183M228.5M44.1M79.5M155M
EBITDA Margin %----------
Interest Expense13.12M11.81M11.95M13M15.6M15.2M13.9M19.4M29.7M34.6M
Non-Operating Income-13.12M-11.81M-11.95M-13M-15.6M-15.2M-13.9M-19.4M-29.7M-34.6M
Pretax Income+129.45M114.23M88.69M19.54M236.4M159.6M210.1M16.5M53.3M128.6M
Pretax Margin %----------
Income Tax+35.97M30.47M-80.77M1.19M52M26.3M39.7M-3.3M8.3M25.8M
Effective Tax Rate %----------
Net Income+93.48M83.77M169.46M18.34M184.4M133.3M170.4M19.8M45M102.8M
Net Margin %----------
Net Income Growth %-0.1%-0.1%1.02%-0.89%9.05%-0.28%0.28%-0.88%1.27%1.28%
EPS (Diluted)+2.202.024.080.444.403.223.390.471.092.48
EPS Growth %-0.11%-0.08%1.02%-0.89%9%-0.27%0.05%-0.86%1.32%1.28%
EPS (Basic)2.302.084.160.454.473.223.450.481.092.49
Diluted Shares Outstanding42.42M41.48M41.56M41.89M41.9M42M42.2M41.8M41.4M41.5M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+10.06B10.58B11.2B11.03B12.48B13.47B14.38B13.31B14.05B14.49B
Asset Growth %0.03%0.05%0.06%-0.01%0.13%0.08%0.07%-0.07%0.06%0.03%
Total Investment Assets+7.65B8B8.35B8.25B6.64B7.26B14.04B6.59B6.83B1.12B
Long-Term Investments175.17M8B300.18M344.66M6.64B7.26B7.45B6.45B6.69B641.1M
Short-Term Investments7.65B8B8.11B7.92B6.15B6.69B6.59B5.37B5.46B480.2M
Total Current Assets+1K1K7.63M395.75M006.72B00938.1M
Cash & Equivalents15.51M16.67M7.63M11.91M25.51M21.8M133M42.2M29M33.1M
Receivables00000001000K1000K1000K
Other Current Assets0000-6.18B-6.71B0-5.88B-5.97B0
Goodwill & Intangibles+47.4M47.4M47.4M47.4M226.3M202M188.9M239.5M224.6M210.1M
Goodwill47.4M47.4M47.4M47.4M49.08M43.5M43.5M54.3M54.3M54.3M
Intangible Assets0000177.22M158.5M145.4M185.2M170.3M155.8M
PP&E (Net)25.64M32.19M38.94M40.98M60.13M64.7M75M69.3M68.6M73.4M
Other Assets-25.64M2.18B10.5B10.14B-6.93B-7.53B6.54B-6.76B-6.98B12.63B
Total Liabilities8.79B9.28B9.7B9.74B10.91B11.68B12.58B12.21B12.87B13.2B
Total Debt+246.97M247.21M297.47M297.74M433.02M437.3M502.6M498M546M547M
Net Debt231.47M230.54M289.84M285.83M407.52M415.5M369.6M455.8M517M513.9M
Long-Term Debt246.97M247.21M297.47M297.74M298.02M302.3M253.6M249M546M547M
Short-Term Debt0000135M135M249M249M00
Total Current Liabilities+000000249M000
Accounts Payable0000000000
Deferred Revenue0000000000
Other Current Liabilities0000-135M-135M0-249M00
Deferred Taxes0000000000
Other Liabilities8.55B9.04B9.4B9.44B-298.02M-302.3M12.32B-249M-546M12.65B
Total Equity+1.26B1.29B1.5B1.29B1.57B1.79B1.81B1.1B1.18B1.29B
Equity Growth %-0.05%0.02%0.16%-0.14%0.21%0.14%0.01%-0.39%0.07%0.1%
Shareholders Equity1.26B1.29B1.5B1.29B1.57B1.79B1.81B1.1B1.18B1.29B
Minority Interest0000000000
Retained Earnings1.12B1.16B1.23B1.22B1.35B1.43B1.52B1.51B1.5B1.55B
Common Stock65K65K65K66K66K100K100K100K100K100K
Accumulated OCI163.37M163.92M286.96M84.76M219.68M355.1M280.5M-399.4M-314M-253.5M
Return on Equity (ROE)0.07%0.07%0.12%0.01%0.13%0.08%0.09%0.01%0.04%0.08%
Return on Assets (ROA)0.01%0.01%0.02%0%0.02%0.01%0.01%0%0%0.01%
Equity / Assets----------
Debt / Equity0.20x0.19x0.20x0.23x0.28x0.24x0.28x0.45x0.46x0.42x
Book Value per Share29.8131.2036.1330.8137.4142.6242.8326.2828.3931.02
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+207.71M207.42M256.59M200.89M127.6M259.79M204.9M171.5M302.1M452.1M
Operating CF Growth %-0.06%-0%0.24%-0.22%-0.36%1.04%-0.21%-0.16%0.76%0.5%
Operating CF / Revenue %----------
Net Income93.48M83.77M169.46M18.34M184.4M133.31M170.4M19.8M45M102.8M
Depreciation & Amortization06.9M6.62M7.36M15.6M23.42M18.4M27.6M26.2M26.4M
Stock-Based Compensation008.59M8.35M7.3M6.7M8.4M8.9M9.5M9.9M
Deferred Taxes0000000000
Other Non-Cash Items439.12M-4.12M-5.19M4.2M-134.4M18.9M-30.5M79.5M9.5M51.4M
Working Capital Changes-324.88M120.88M77.11M162.65M54.7M77.46M38.2M35.7M211.9M261.6M
Cash from Investing+-415.85M-325.36M-228.66M-186.5M55.9M-406.76M-302M-214.6M-107.4M-135.8M
Capital Expenditures0000000000
Acquisitions000-76.55M-459.4M0-234.1M-164.4M-165.8M0
Purchase of Investments-1.53B00-1.5B-1.12B-1.48B-1.51B0-639M-1.24B
Sale/Maturity of Investments1000K001000K1000K1000K1000K01000K1000K
Other Investing-33.92M-325.36M-228.66M00-67.72M-10.2M-50.2M9.2M7.2M
Cash from Financing+212.64M115.09M-36.97M-10.11M-169.9M143.78M208.5M-47.8M-207.8M-307.9M
Dividends Paid-42.52M-44.31M-46.11M-46.69M-47.3M-49.62M-51.4M-52.6M-53.9M-55.5M
Share Repurchases-21.95M-21.51M-1.66M-5.09M0-2.2M-5.3M-24M-6.5M-8.6M
Stock Issued0000000005.1M
Debt Issuance (Net)1000K1000K1000K1000K-1000K1000K-1000K-1000K-1000K-1000K
Other Financing267.38M173.68M-31.2M19.8M47.4M191.6M562.2M182.8M-6.6M18.6M
Net Change in Cash+3.83M1.16M-9.04M4.28M13.6M-3.2M111.4M-90.9M-13.1M8.4M
Exchange Rate Effect0000000000
Cash at Beginning11.68M15.51M16.67M7.63M11.9M25.5M22.3M133.7M42.8M29.7M
Cash at End15.51M16.67M7.63M11.91M25.5M22.3M133.7M42.8M29.7M38.1M
Free Cash Flow+40.8M207.42M256.59M200.89M127.6M259.8M204.9M171.5M302.1M452.1M
FCF Growth %-0.82%4.08%0.24%-0.22%-0.36%1.04%-0.21%-0.16%0.76%0.5%
FCF Margin %----------
FCF per Share0.9656.174.83.056.194.864.17.310.89

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio88.02%89.88%92.43%98.34%83.17%87.62%83.2%98.77%96.28%91.71%
Medical Cost Ratio72.02%73.5%75.38%81.08%64.57%67.73%67.29%75.21%75.1%69.14%
Return on Equity (ROE)7.19%6.55%12.12%1.31%12.9%7.94%9.47%1.36%3.96%8.35%
Return on Assets (ROA)0.94%0.81%1.56%0.17%1.57%1.03%1.22%0.14%0.33%0.72%
Equity / Assets12.57%12.23%13.41%11.7%12.56%13.29%12.57%8.25%8.37%8.89%
Book Value / Share29.8131.236.1330.8137.4142.6242.8326.2828.3931.02
Debt / Equity0.20x0.19x0.20x0.23x0.28x0.24x0.28x0.45x0.46x0.42x
Revenue Growth1.86%4.49%3.78%0.4%19.44%-8.21%-3.04%7.26%6.84%8.21%

Revenue by Segment

2015201620172018201920202021202220232024
Property and Casualty-------608.2M645.5M736.5M
Property and Casualty Growth--------6.13%14.10%
Life And Retirement-------145.3M151.8M154.6M
Life And Retirement Growth--------4.47%1.84%
Product And Casualty------617.4M---
Product And Casualty Growth----------
Supplemental------125.3M---
Supplemental Growth----------
Life And Health------108.4M---
Life And Health Growth----------
Retirement------38.5M---
Retirement Growth----------
Product and Casualty----683.45M650.17M----
Product and Casualty Growth------4.87%----
Supplemental----65.81M130.69M----
Supplemental Growth-----98.58%----
Life and Health----119.6M120.19M----
Life and Health Growth-----0.49%----
Annuity Insurance Product Line25.38M24.94M28M31.27M29.08M29.65M----
Annuity Insurance Product Line Growth--1.74%12.29%11.66%-6.99%1.95%----
Property, Liability and Casualty Insurance Product Line595.96M620.51M648.26M665.73M------
Property, Liability and Casualty Insurance Product Line Growth-4.12%4.47%2.70%------
Life Insurance Product Line110.54M113.69M118.44M120.33M------
Life Insurance Product Line Growth-2.85%4.17%1.60%------
Other Insurance Product Line----------
Other Insurance Product Line Growth----------

Frequently Asked Questions

Valuation & Price

Horace Mann Educators Corporation (HMN) has a price-to-earnings (P/E) ratio of 17.3x. This is roughly in line with market averages.

Growth & Financials

Horace Mann Educators Corporation (HMN) grew revenue by 8.2% over the past year. This is steady growth.

Yes, Horace Mann Educators Corporation (HMN) is profitable, generating $164.1M in net income for fiscal year 2024 (6.6% net margin).

Dividend & Returns

Yes, Horace Mann Educators Corporation (HMN) pays a dividend with a yield of 3.12%. This makes it attractive for income-focused investors.

Horace Mann Educators Corporation (HMN) has a return on equity (ROE) of 8.3%. This is below average, suggesting room for improvement.

Industry Metrics

Horace Mann Educators Corporation (HMN) has a combined ratio of 91.7%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.